Unbiased Analysis of Today's Healthcare Issues

What’s at stake if U.S. drug prices fall?

In his 2018 State of the Union address, President Trump said that “fixing the injustice of high drug prices” will be one of the top priorities of his administration in the coming year. Lower drug prices could directly benefit consumers without insurance or those with high-deductible health plans; commercially insured individuals could hope to see […]

Read the rest of this entry »

Cost of Cancer in Europe

In 2008, 2.45 million people were diagnosed with cancer and 1.23 million died because of cancer in the European Union (EU). What is the economic burden of cancer?  A paper by Luengo-Fernandez (2013) aims to estimate just this quantity.  They find that: Cancer cost the EU €126 billion in 2009…Across the EU, the health-care costs […]

Read the rest of this entry »

Socioeconomic Status and Wait Times in Europe

One of the most contentious parts of the healthcare debate in the U.S. is whether or not to move towards a more European style of health care.  Those in favor cite the equality of the system, the lower cost, and lower administrative cost.  Those against rail against the lack of provider choice and the long […]

Read the rest of this entry »